Suchergebnisse - Kurt Cooper

  • Treffer 1 - 3 von 3
Treffer weiter einschränken
  1. 1
    Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever

    Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever von Tiago Abreu-Mota, Katie R. Hagen, Kurt Cooper, Peter B. Jahrling, Gene S. Tan, Christoph Wirblich, Reed F. Johnson, Matthias J. Schnell

    Veröffentlicht 2018
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    An Inactivated Rabies Virus–Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models

    An Inactivated Rabies Virus–Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Model... von Reed F. Johnson, Drishya Kurup, Katie R. Hagen, Christine R. Fisher, Rohan Keshwara, Amy B. Papaneri, Donna L. Perry, Kurt Cooper, Peter B. Jahrling, Jonathan T. Wang, Jan ter Meulen, Christoph Wirblich, Matthias J. Schnell

    Veröffentlicht 2016
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene

    A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene von Yíngyún Caì, Chengjin Ye, Benson Yee Hin Cheng, Aitor Nogales, Masaharu Iwasaki, Shuǐqìng Yú, Kurt Cooper, David X. Liu, Randy Hart, Ricky Adams, Tyler Brady, Elena Postnikova, Jonathan Kurtz, Marisa St. Claire, Jens H. Kuhn, Juan Carlos de la Torre, Luis Martínez‐Sobrido

    Veröffentlicht 2020
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: